go back

CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)

CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)
NEONATAL INTRAHEPATIC CHOLESTASIS CAUSED BY CITRIN DEFICIENCY, NICCD
605814
OMIM = Online Mendelian Inheritance of Men
247598
citrin deficiency, calcium-binding mitochondrial carrier protein Aralar2
7q21.3
E72.2
rare
autosomal recessive
mutation in the SLC25A13 gene

The profiles of blood amino acid in early neonates with NICCD present
the increased levels of multiple amino acids including citrulline,
tyrosine, methionine and phenylalanine, and decreased ratio of Ala/Cit [Tang CF 2019]
Laboratory findingsCitrulline inc (plasma)
D-Galactose normal/inc (plasma)
    4-Hydroxyphenyllactic acid inc (urine)
    Acylcarnitine (C2) inc (blood)
    alpha-Fetoprotein inc (plasma)
    Bilirubin inc (serum)
    D-Galactose inc (urine)
    L-Carnitine inc (plasma)
    L-Threonine inc (plasma)
    L-Tyrosine inc (plasma)
    Methionine inc (plasma)
    Palmitoylcarnitine (C16) inc (blood)
    Phenylalanine inc (dried blood spot (DB)
    Propionylcarnitine (C3) inc (blood)
    Protein, total dec (serum)
    Stearoylcarnitine (C18) inc (blood)
    Transaminases (ASAT/ALAT) normal/inc (serum)
Symptoms   cholestasis
   coma
   developmental delay
   encephalopathy
   jaundice
   liver involvement or dysfunction
    ataxia
    bleeding tendencies, hemorrhages
    cirrhosis or fibrosis of liver
    Coagulopathy/Coagulation factors
    failure to thrive
    hepatomegaly (large liver)
    hypoglycemia
    liver steatosis
    liver, fatty
    onset, neonatal